Help Print this page 

Document 32014B0328(31)

Title and reference
Statement of revenue and expenditure of the Innovative Medicines Initiative Joint Undertaking for the financial year 2014
  • No longer in force, Date of end of validity: 31/12/2014
OJ C 90, 28.3.2014, p. 165–170 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Languages, formats and link to OJ
BG ES CS DA DE ET EL EN FR GA HR IT LV LT HU MT NL PL PT RO SK SL FI SV
HTML html BG html ES html CS html DA html DE html ET html EL html EN html FR html HR html IT html LV html LT html HU html MT html NL html PL html PT html RO html SK html SL html FI html SV
PDF pdf BG pdf ES pdf CS pdf DA pdf DE pdf ET pdf EL pdf EN pdf FR pdf HR pdf IT pdf LV pdf LT pdf HU pdf MT pdf NL pdf PL pdf PT pdf RO pdf SK pdf SL pdf FI pdf SV
Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal
 To see if this document has been published in an e-OJ with legal value, click on the icon above (For OJs published before 1st July 2013, only the paper version has legal value).
Multilingual display
Text

28.3.2014   

EN

Official Journal of the European Union

C 90/165


Statement of revenue and expenditure of the Innovative Medicines Initiative Joint Undertaking for the financial year 2014

(2014/C 90/31)

REVENUE

Title

Chapter

Heading

Financial year 2014

Financial year 2013

Financial year 2012

Commitments

Payments

Commitments

Payments

Payments

1

SUBSIDIES AND CONTRIBUTIONS

1 0

SUBSIDY FROM EUROPEAN COMMISSION

3 950 000

165 137 993

200 229 206

125 829 159

97 783 960,—

 

Title 1 — Total

3 950 000

165 137 993

200 229 206

125 829 159

97 783 960,—

2

SUBSIDY FROM THE EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS (EFPIA)

2 0

SUBSIDY FROM THE EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS (EFPIA)

3 950 000

3 950 000

4 200 000

4 200 000

4 067 578,—

 

Title 2 — Total

3 950 000

3 950 000

4 200 000

4 200 000

4 067 578,—

3

CARRY OVER FROM PREVIOUS YEARS

3 0

CARRY OVER FROM PREVIOUS YEARS AND BANK INTEREST

880 903

733 257

51 286 713

529 463

10 675 203,—

 

Title 3 — Total

880 903

733 257

51 286 713

529 463

10 675 203,—

 

GRAND TOTAL

8 780 903

169 821 250

255 715 919

130 558 622

112 526 741,—

EXPENDITURE

Title

Chapter

Heading

Appropriations 2014

Appropriations 2013

Outturn 2012

Commitments

Payments

Commitments

Payments

Payments

1

STAFF

1 1

STAFF IN ACTIVE EMPLOYMENT

4 131 000

4 131 000

4 131 000

4 131 000

3 427 087,—

1 2

STAFF RECRUITMENTS/MISCELLANEOUS EXPENDITURE

10 000

10 000

20 000

20 000

14 561,—

1 3

MISSIONS AND DUTY TRAVELS

160 000

160 000

160 000

160 000

105 262,—

1 4

OTHER STAFF COSTS (SOCIOMEDICAL STRUCTURE)

220 000

220 000

200 000

200 000

125 991,—

1 7

ENTERTAINMENT AND REPRESENTATION EXPENSES

20 000

20 000

30 000

30 000

4 489,—

 

Title 1 — Total

4 541 000

4 541 000

4 541 000

4 541 000

3 677 390,—

2

OTHER ADMINISTRATIVE EXPENDITURE

2 0

RENTAL OF BUILDING AND ASSOCIATED COSTS

450 000

450 000

455 000

455 000

393 937,—

2 1

INFORMATION TECHNOLOGY

450 000

450 000

630 000

630 000

376 528,—

2 2

MOVABLE PROPERTY AND ASSOCIATED COSTS

80 000

80 000

72 000

72 000

7 423,—

2 3

CURRENT ADMINISTRATIVE EXPENDITURE

100 000

100 000

113 000

113 000

54 366,—

2 4

TELECOMMUNICATIONS AND POSTAL CHARGES

59 000

59 000

70 000

70 000

23 927,—

2 5

EXPENDITURES ON FORMAL MEETINGS

140 000

140 000

150 000

150 000

88 766,—

2 6

RUNNING COSTS IN CONNECTION WITH OPERATIONAL ACTIVITIES

500 000

500 000

500 000

500 000

197 444,—

2 7

EXTERNAL COMMUNICATION, INFORMATION AND PUBLICITY

500 000

500 000

500 000

500 000

276 206,—

2 8

STUDIES AND EX-POST AUDIT

580 000

580 000

800 000

800 000

30 293,—

2 9

EXPERT CONTRACTS AND COSTS OF EVALUATIONS

500 000

500 000

569 000

569 000

533 488,—

 

Title 2 — Total

3 359 000

3 359 000

3 859 000

3 859 000

1 982 378,—

3

OPERATIONAL ACTIVITIES

3 0

IMPLEMENTING THE RESEARCH AGENDA OF IMI JU

161 187 993

196 029 206

121 629 159

93 133 960,—

3 1

CARRY-OVER AND BANK INTEREST

880 903

733 257

51 286 713

529 463

10 675 203,—

 

Title 3 — Total

880 903

161 921 250

247 315 919

122 158 622

103 809 163,—

 

GRAND TOTAL

8 780 903

169 821 250

255 715 919

130 558 622

109 468 931,—

Establishment plan

Function group and grade

2012

2013

2014

Permanent posts

Temporary posts

Permanent posts

Temporary posts

Permanent posts

Temporary posts

AD 16

AD 15

AD 14

1

1

1

AD 13

AD 12

1

1

1

AD 11

4

4

4

AD 10

AD 9

5

5

5

AD 8

11

11

11

AD 7

1

1

1

AD 6

AD 5

Total AD

23

23

23

AST 11

AST 10

AST 9

AST 8

1

1

1

AST 7

AST 6

AST 5

AST 4

AST 3

5

5

5

AST 2

AST 1

Total AST

6

6

6

Total

29

29

29

Grand Total

 

29

Estimate of number of contract staff (expressed in full-time equivalents) and seconded national experts

Contract staff posts

2014

FG IV

2

FG III

4

FG II

1

FG I

Total FG

7

Seconded national experts posts

Total

7


Top